These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease. Linazasoro G; J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015 [TBL] [Abstract][Full Text] [Related]
34. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists. Kim JY; Chung EJ; Park SW; Lee WY Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692 [TBL] [Abstract][Full Text] [Related]
35. [Ropinirole in the treatment of Parkinson's disease: an update]. Vivancos-Matellano F Rev Neurol; 2006 May 1-15; 42(9):542-8. PubMed ID: 16676278 [TBL] [Abstract][Full Text] [Related]
36. Dopamine agonists in the treatment of Parkinson's disease. Bonuccelli U; Pavese N Expert Rev Neurother; 2006 Jan; 6(1):81-9. PubMed ID: 16466315 [TBL] [Abstract][Full Text] [Related]
37. Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson's disease. Montastruc F; Moulis F; Araujo M; Chebane L; Rascol O; Montastruc JL Eur J Clin Pharmacol; 2017 Jan; 73(1):99-103. PubMed ID: 27796464 [TBL] [Abstract][Full Text] [Related]
38. Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature. Thobois S Clin Ther; 2006 Jan; 28(1):1-12. PubMed ID: 16490575 [TBL] [Abstract][Full Text] [Related]
39. Dopamine agonists. Their role in the management of Parkinson's disease. Rascol O; Ferreira JJ; Thalamas C; Galitsky M; Montastruc JL Adv Neurol; 2001; 86():301-9. PubMed ID: 11553990 [No Abstract] [Full Text] [Related]
40. Treatment of early Parkinson's disease. Dickerson LM; Young SE; Simpson WM; Nashelsky J Am Fam Physician; 2005 Aug; 72(3):497-500. PubMed ID: 16100865 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]